Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From 'polycystic ovary syndrome' to 'polyendocrine metabolic ovarian syndrome': why terminology matters.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same author

Drawbacks in dopaminergic neurotransmission: compromising sexual performance.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same author

Early in, early out: reproductive lifespan timing and cardiometabolic risk in women.

Journal of endocrinological investigation·2026
Same author

Fezolinetant treatment for hot flashes associated with menopause: A plain language summary of the DAYLIGHT study.

Women's health (London, England)·2026
Same author

A meta-umbrella review of risk factors for vulvodynia: evidence from demographic, psychosocial, and biomedical domains.

The journal of sexual medicine·2026
Same author

Reproductive transitions and autoimmunity: implications for women's health in rheumatology and gastroenterology.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same journal

European society of gynecology (ESG) position paper on the proposed terminology change from PCOS to PMOS.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same journal

Peripheral precocious puberty with unilateral ovarian agenesis in early childhood: a case report and review of literature.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same journal

Transdermal versus oral hormone replacement therapy and bone mass density in Turner syndrome patients: a pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same journal

Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same journal

Progestin therapy in premenopausal women with incidental meningioma-a narrative review and recommendations for women's health specialists.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
Same journal

Inter-rater reliability and clinical utility of the modified ferriman-gallwey scale in routine practice.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Reproductive depression.

John Studd1, Rossella E Nappi

  • 1London PMS and Menopause Centre, London, UK.

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|March 8, 2012
PubMed
Summary
This summary is machine-generated.

Reproductive depression, linked to hormonal shifts, is effectively treated with transdermal estrogens as a first-line therapy over antidepressants. Early intervention, especially for postnatal depression, is crucial for long-term mood health.

More Related Videos

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

Related Experiment Videos

Last Updated: May 24, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

Area of Science:

  • Reproductive psychiatry
  • Women's health
  • Endocrinology

Background:

  • Reproductive depression encompasses premenstrual, postnatal, and climacteric depression, linked to hormonal fluctuations.
  • These conditions often affect the same vulnerable women, indicating a cyclical pattern.
  • Current treatments may include antidepressants, but hormonal therapies are increasingly considered.

Purpose of the Study:

  • To highlight transdermal estrogens as a primary treatment for reproductive depression.
  • To emphasize the importance of treating postnatal depression to prevent long-term mood issues.
  • To discuss adjunctive therapies like testosterone and management of progestogen intolerance.

Main Methods:

  • Review of clinical presentations and treatment outcomes for reproductive depression.
  • Analysis of hormonal influences on mood disorders across the female lifespan.
  • Evaluation of therapeutic efficacy of transdermal estrogens, antidepressants, and testosterone.

Main Results:

  • Transdermal estrogens demonstrate effectiveness and should be the preferred initial therapy for reproductive depression.
  • Antidepressants can be used adjunctively with estrogens.
  • Transdermal testosterone can improve energy and libido in women experiencing side effects from antidepressants.

Conclusions:

  • Transdermal estrogens are recommended as the first-choice treatment for premenstrual, postnatal, and climacteric depression.
  • Appropriate management of postnatal depression is critical for preventing chronic mood disorders.
  • Individualized treatment strategies, including managing progestogen intolerance, are essential for reproductive depression.